AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015)
AbbVie's Current Deferred Tax Assets was $1.1 billion in Q3 2015, up 109.9% from $524 million a year earlier but down 10.4% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Current Deferred Tax Assets (2012 - 2015) Analysis & Trends
At the end of FY2014, Current Deferred Tax Assets at AbbVie came in at $896 million, up 17.0% from FY2013.
- In earlier years, Current Deferred Tax Assets was $766 million in FY2013 (+14.5%) and $669 million in FY2012.
- Quarterly Current Deferred Tax Assets has moved between $524 million (Q3 2014) and $1.44 billion (Q2 2013) over five years.
- Compared with a year earlier, Current Deferred Tax Assets was higher in four of the last eight quarters, with growth averaging 5.2%.
- The best year-over-year quarter for Current Deferred Tax Assets over five years was Q3 2015 (growth of 109.9%); the worst was Q3 2014 (a decline of 63.1%).
- Per Business Quant data, ABBV's Current Deferred Tax Assets in the three quarters before Q3 2015 was $1.23 billion (Q2 2015), $1.06 billion (Q1 2015) and $896 million (Q4 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 1.10 Bn |
| Jun 30, 2015 | 1.23 Bn |
| Mar 31, 2015 | 1.06 Bn |
| Dec 31, 2014 | 896.00 Mn |
| Sep 30, 2014 | 524.00 Mn |
| Jun 30, 2014 | 1.10 Bn |
| Mar 31, 2014 | 1.08 Bn |
| Dec 31, 2013 | 766.00 Mn |
| Sep 30, 2013 | 1.42 Bn |
| Jun 30, 2013 | 1.44 Bn |
| Mar 31, 2013 | 1.40 Bn |
| Dec 31, 2012 | 669.00 Mn |
API Access
AbbVie Current Deferred Tax Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-tax-assets", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();